Guangdong Marubi Stock Soars 10.02%, Hits Intraday High of CNY 25.58

Guangdong Marubi Biotechnology Co., Ltd. has experienced significant activity today, with the stock rising by 10.02% as of June 29, 2026. The stock reached an intraday high of CNY 25.58, marking a notable performance against the backdrop of the China Shanghai Composite, which only gained 1.16% on the same day. Over the past week, Guangdong Marubi has shown a robust increase of 18.48%, contrasting sharply with the China Shanghai Composite's decline of 2.14%. However, the company's performance over the longer term reveals a more complex picture. Year-to-date, the stock has decreased by 22.84%, and over the past year, it has generated a return of -38.0%, significantly underperforming the benchmark index, which has risen by 18.97%. Despite the recent uptick, the company has faced challenges in long-term growth, with net sales increasing at an annual rate of 14.97% and operating profit declining by 6.64% over the last five years. The stock currently boasts a price-to-earnings ratio of 42.00 and a dividend yield of 3.37%, indicating a mixed financial outlook.